Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

COURTNEY D SHELTON

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1609874023
CMS profile
344672
Location
ATLANTA, GA

General Payments · PY2018–2024

$3,236.44

  • Reported across 105 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$270.11

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $270.11 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $72.51 4
GlaxoSmithKline, LLC. $53.27 2
Bayer HealthCare Pharmaceuticals Inc. $49.53 2
Lilly USA, LLC $48.01 3
Novo Nordisk AS $24.09 1
Exact Sciences Corporation $22.70 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $870.50 9
PY2019 $22.42 1
PY2020 $125.30 6
PY2021 $652.61 23
PY2022 $862.75 36
PY2023 $432.75 17
PY2024 $270.11 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $23.92 02/06/2024 Food and Beverage Undisputed 01/23/2026 1105421362 CMS
AstraZeneca Pharmaceuticals LP $13.55 02/15/2024 Food and Beverage Undisputed 01/23/2026 1105799074 CMS
AstraZeneca Pharmaceuticals LP $19.38 08/13/2024 Food and Beverage Undisputed 01/23/2026 1105746789 CMS
AstraZeneca Pharmaceuticals LP $15.66 11/21/2024 Food and Beverage Undisputed 01/23/2026 1105589044 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.64 07/31/2024 Food and Beverage Undisputed 01/23/2026 1086203217 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.89 10/28/2024 Food and Beverage Undisputed 01/23/2026 1086138155 CMS
Exact Sciences Corporation $22.70 12/03/2024 Food and Beverage Undisputed 01/23/2026 1114893718 CMS
GlaxoSmithKline, LLC. $23.62 03/13/2024 Food and Beverage Undisputed 01/23/2026 1115994494 CMS
GlaxoSmithKline, LLC. $29.65 08/29/2024 Food and Beverage Undisputed 01/23/2026 1116695481 CMS
Lilly USA, LLC $15.02 04/22/2024 Food and Beverage Undisputed 01/23/2026 1136118835 CMS
Lilly USA, LLC $15.37 07/31/2024 Food and Beverage Undisputed 01/23/2026 1136118837 CMS
Lilly USA, LLC $17.62 09/26/2024 Food and Beverage Undisputed 01/23/2026 1136131496 CMS
Novo Nordisk Inc $24.09 01/29/2024 Food and Beverage Undisputed 01/23/2026 1097359293 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.